(VIANEWS) – CrowdStrike Holdings (CRWD), Rexford Industrial Realty (REXR), Catalyst Pharmaceuticals (CPRX) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. CrowdStrike Holdings (CRWD)
22% sales growth and 7.33% return on equity
CrowdStrike Holdings, Inc. provides cybersecurity solutions in the United States and internationally. Its unified platform offers cloud-delivered protection of endpoints, cloud workloads, identity, and data. The company offers corporate endpoint and cloud workload security, managed security, security and vulnerability management, IT operations management, identity protection, SIEM and log management, threat intelligence, data protection, security orchestration, automation and response and AI powered workflow automation, and securing generative AI workload services. It primarily sells subscriptions to its Falcon platform and cloud modules. The company was incorporated in 2011 and is headquartered in Austin, Texas.
Earnings Per Share
As for profitability, CrowdStrike Holdings has a trailing twelve months EPS of $0.38.
PE Ratio
CrowdStrike Holdings has a trailing twelve months price to earnings ratio of 813.29. Meaning, the purchaser of the share is investing $813.29 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.33%.
Sales Growth
CrowdStrike Holdings’s sales growth for the next quarter is 22%.
Moving Average
CrowdStrike Holdings’s worth is above its 50-day moving average of $291.81 and higher than its 200-day moving average of $300.93.
Yearly Top and Bottom Value
CrowdStrike Holdings’s stock is valued at $309.05 at 16:22 EST, way below its 52-week high of $398.33 and way higher than its 52-week low of $157.59.
Volume
Today’s last reported volume for CrowdStrike Holdings is 2142290 which is 42.86% below its average volume of 3749830.
2. Rexford Industrial Realty (REXR)
17.1% sales growth and 3.5% return on equity
Rexford Industrial creates value by investing in, operating and redeveloping industrial properties throughout infill Southern California, the world's fourth largest industrial market and consistently the highest-demand with lowest-supply major market in the nation. The Company's highly differentiated strategy enables internal and external growth opportunities through its proprietary value creation and asset management capabilities. Rexford Industrial's high-quality, irreplaceable portfolio comprises 371 properties with approximately 45.0 million rentable square feet occupied by a stable and diverse tenant base. Structured as a real estate investment trust (REIT) listed on the New York Stock Exchange under the ticker "REXR," Rexford Industrial is an S&P MidCap 400 Index member.
Earnings Per Share
As for profitability, Rexford Industrial Realty has a trailing twelve months EPS of $1.21.
PE Ratio
Rexford Industrial Realty has a trailing twelve months price to earnings ratio of 43.18. Meaning, the purchaser of the share is investing $43.18 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.5%.
Moving Average
Rexford Industrial Realty’s worth is higher than its 50-day moving average of $48.24 and higher than its 200-day moving average of $49.38.
Sales Growth
Rexford Industrial Realty’s sales growth is 18.2% for the ongoing quarter and 17.1% for the next.
Yearly Top and Bottom Value
Rexford Industrial Realty’s stock is valued at $52.25 at 16:22 EST, under its 52-week high of $58.02 and way above its 52-week low of $41.56.
3. Catalyst Pharmaceuticals (CPRX)
16.7% sales growth and 13.85% return on equity
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company develops Firdapse for the treatment of MuSK antibody positive myasthenia gravis and spinal muscular atrophy type. It has license agreements with BioMarin Pharmaceutical Inc.; and collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. The company was founded in 2002 and is based in Coral Gables, Florida.
Earnings Per Share
As for profitability, Catalyst Pharmaceuticals has a trailing twelve months EPS of $0.63.
PE Ratio
Catalyst Pharmaceuticals has a trailing twelve months price to earnings ratio of 24.16. Meaning, the purchaser of the share is investing $24.16 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.85%.
4. Medpace Holdings (MEDP)
11.2% sales growth and 58.85% return on equity
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
Earnings Per Share
As for profitability, Medpace Holdings has a trailing twelve months EPS of $10.64.
PE Ratio
Medpace Holdings has a trailing twelve months price to earnings ratio of 31.55. Meaning, the purchaser of the share is investing $31.55 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 58.85%.
5. Lincoln Educational Services Corporation (LINC)
7.8% sales growth and 4.99% return on equity
Lincoln Educational Services Corporation, together with its subsidiaries, provides various career-oriented post-secondary education services to high school graduates and working adults in the United States. The company operates in two segments: Transportation and Skilled Trades, and Healthcare and Other Professions. It offers associate's degree, and diploma and certificate programs in automotive technology; skilled trades programs, including electrical, heating and air conditioning repair, welding, computerized numerical control, and electrical and electronic systems technology; health science programs comprising s licensed practical nurse, registered nurse, dental assistant, medical assistant, medical administrative assistant, and claims examiner; hospitality service programs, such as culinary, therapeutic massage, cosmetology, and aesthetics; and information technology programs. The company operates schools under the Lincoln Technical Institute, Lincoln College of Technology, Lincoln Culinary Institute, Euphoria Institute of Beauty Arts and Sciences, and other brand names. Lincoln Educational Services Corporation was founded in 1946 and is based in Parsippany, New Jersey.
Earnings Per Share
As for profitability, Lincoln Educational Services Corporation has a trailing twelve months EPS of $0.25.
PE Ratio
Lincoln Educational Services Corporation has a trailing twelve months price to earnings ratio of 49.8. Meaning, the purchaser of the share is investing $49.8 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.99%.
Sales Growth
Lincoln Educational Services Corporation’s sales growth for the next quarter is 7.8%.
Volume
Today’s last reported volume for Lincoln Educational Services Corporation is 37658 which is 74.31% below its average volume of 146614.
